Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment (Q44349229)

reason for preferred rank

2 December 2017

title

Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

1 January 2023

Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362035

1 January 2023

0 references

B. C. Yoburn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362035

1 January 2023

C. E. Inturrisi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3362035

1 January 2023

language of work or name

English

0 references

publication date

1 January 1988

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:0024320588900343?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

https://api.elsevier.com/content/article/PII:0024320588900343?httpAccept=text/plain

1 January 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

1 January 2023

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

1689-1696

1 reference

Chronic naloxone results in prolonged increases in opiate binding sites in brain

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Naltrexone-induced opiate receptor supersensitivity

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Elevated beta-adrenergic receptor number after chronic propranolol treatment

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Increased muscarinic receptor binding in rat forebrain after scopolamine

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Central cholinergic receptor supersensitivity after long-term atropine administration

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Pupillary supersensitivity to substance P following prolonged treatment with tetrodotoxin or substance P antagonists

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Naloxone attenuation of the effect of cocaine on rewarding brain stimulation

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

Cocaine: effect of in vivo administration on synaptosomal uptake of norepinephrine.

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

1 January 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(88)90034-3

1 January 2023

Identifiers

DOI

1 reference

release_dfhozvd6n5ft5bmezx4v366i5u

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dfhozvd6n5ft5bmezx4v366i5u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference